Company · Incheon, --, Korea, Republic Of
Celltrion Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 36
- 35 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 34
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| AVTOZMA | 02562022 | Marketed | |
| AVTOZMA | 02562030 | Marketed | |
| AVTOZMA | 02562049 | Marketed | |
| AVTOZMA | 02562057 | Marketed | |
| AVTOZMA | 02562065 | Marketed | |
| EYDENZELT | 02563037 | Marketed | |
| EYDENZELT | 02563045 | Marketed | |
| HERZUMA | 02480794 | Marketed | |
| HERZUMA | 02506211 | Marketed | |
| OMLYCLO | 02553805 | Marketed | |
| OMLYCLO | 02553813 | Marketed | |
| OMLYCLO | 02561018 | Marketed | |
| OMLYCLO | 02561026 | Marketed | |
| OSENVELT | 02560895 | Marketed | |
| REMDANTRY | 02419475 | Marketed | |
| REMSIMA SC | 02511584 | Marketed | |
| STEQEYMA | 02550245 | Marketed | |
| STEQEYMA | 02550253 | Marketed | |
| STEQEYMA | 02566540 | Marketed | |
| STEQEYMA IV | 02550261 | Marketed | |
| STOBOCLO | 02560917 | Marketed | |
| TRUXIMA | 02478382 | Marketed | |
| TRUXIMA | 02478390 | Marketed | |
| VEGZELMA | 02534177 | Marketed | |
| VEGZELMA | 02534185 | Marketed | |
| YUFLYMA | 02523760 | Marketed | |
| YUFLYMA | 02523779 | Marketed | |
| YUFLYMA | 02535076 | Marketed | |
| YUFLYMA | 02535084 | Marketed | |
| OMLYCLO | 02565013 | Approved | |
| OMLYCLO | 02565021 | Approved | |
| REMSIMA SC | 02511576 | Approved | |
| STEQEYMA | 02558270 | Approved | |
| STEQEYMA | 02566532 | Approved | |
| YUFLYMA | 02556596 | Approved | |
| REMSIMA | 02419483 | Cancelled Post Market |
Notices of Compliance
Newest first.
- VEGZELMASeptember 22, 2026 · NOC 38331 · Supplement to a New Drug Submission (SNDS)
- REMSIMA SCSeptember 17, 2026 · NOC 38305 · Supplement to a New Drug Submission (SNDS)
- AVTOZMAAugust 4, 2026 · NOC 38033 · Supplement to a New Drug Submission (SNDS)
- EYDENZELTJuly 20, 2026 · NOC 37939 · Supplement to a New Drug Submission (SNDS)
- REMDANTRYJuly 15, 2026 · NOC 37904 · Supplement to a New Drug Submission (SNDS)
- TRUXIMAMay 27, 2026 · NOC 37615 · Supplement to a New Drug Submission (SNDS)
- STOBOCLOMay 18, 2026 · NOC 37568 · Supplement to a New Drug Submission (SNDS)
- STEQEYMA; STEQEYMA I.V.April 15, 2026 · NOC 37337 · Supplement to a New Drug Submission (SNDS)
- STEQEYMA; STEQEYMA I.V.March 13, 2026 · NOC 37104 · Supplement to a New Drug Submission (SNDS)
- HERZUMAFebruary 17, 2026 · NOC 36948 · Supplement to a New Drug Submission (SNDS)
- OMLYCLOJanuary 23, 2026 · NOC 36785 · Supplement to a New Drug Submission (SNDS)
- EYDENZELTNovember 24, 2025 · NOC 36435 · New Drug Submission (NDS)
- REMDANTRYNovember 18, 2025 · NOC 36425 · Supplement to a New Drug Submission (SNDS)
- REMSIMA SCNovember 18, 2025 · NOC 36427 · Supplement to a New Drug Submission (SNDS)
- OMLYCLOOctober 31, 2025 · NOC 36326 · Supplement to a New Drug Submission (SNDS)
- AVTOZMAOctober 16, 2025 · NOC 36201 · New Drug Submission (NDS)
- STOBOCLOSeptember 17, 2025 · NOC 36026 · New Drug Submission (NDS)
- OSENVELTSeptember 17, 2025 · NOC 36027 · New Drug Submission (NDS)
- OMLYCLOSeptember 9, 2025 · NOC 35977 · Supplement to a New Drug Submission (SNDS)
- REMDANTRYSeptember 2, 2025 · NOC 36110 · Supplement to a New Drug Submission (SNDS)
- YUFLYMAJune 19, 2025 · NOC 35571 · Supplement to a New Drug Submission (SNDS)
- STEQEYMA; STEQEYMA I.V.June 4, 2025 · NOC 35471 · Supplement to a New Drug Submission (SNDS)
- VEGZELMAMarch 31, 2025 · NOC 35121 · Supplement to a New Drug Submission (SNDS)
- REMDANTRYMarch 7, 2025 · NOC 35007 · Supplement to a New Drug Submission (SNDS)
- STEQEYMA; STEQEYMA I.V.February 28, 2025 · NOC 34931 · Supplement to a New Drug Submission (SNDS)
- REMSIMAJanuary 9, 2025 · NOC 34660 · Supplement to a New Drug Submission (SNDS)
- OMLYCLODecember 6, 2024 · NOC 34519 · New Drug Submission (NDS)
- HERZUMAOctober 3, 2024 · NOC 34144 · New Drug Submission (NDS)
- INFLECTRASeptember 4, 2024 · NOC 34034 · New Drug Submission (NDS)
- TRUXIMAAugust 22, 2024 · NOC 33881 · New Drug Submission (NDS)
- STEQEYMA; STEQEYMA I.V.July 30, 2024 · NOC 33732 · New Drug Submission (NDS)
- REMSIMA; REMSIMA SCJune 28, 2024 · NOC 33539 · New Drug Submission (NDS)
- YUFLYMAJune 21, 2024 · NOC 33538 · New Drug Submission (NDS)
- VEGZELMAMarch 28, 2024 · NOC 32981 · New Drug Submission (NDS)